1. Home
  2. Labeler Index
  3. Asclemed Usa, Inc.
  4. 76420-771
  5. NDC Package Code: 76420-771-01 Ketorocaine L Kit

NDC Package 76420-771-01 Ketorocaine L Kit

Ketorolac Tromethamine,Lidocaine Hydrochloride,Povidine Iodine Kit Infiltration; - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
76420-771-01
Package Description:
1 KIT in 1 CARTON * 10 AMPULE in 1 CARTON (55150-158-72) / 2 mL in 1 AMPULE * .9 mL in 1 PACKET (67777-419-02) * 5 mL in 1 POUCH * 1 mL in 1 VIAL (72266-118-01)
Product Code:
76420-771
Proprietary Name:
Ketorocaine L Kit
Non-Proprietary Name:
Ketorolac Tromethamine, Lidocaine Hydrochloride, Povidine Iodine
Usage Information:
Carefully consider the potential benefits and risks of ketorolac tromethamine and other treatment options before deciding to use ketorolac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).Acute Pain in Adult PatientsKetorolac tromethamine is indicated for the short-term (≤5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. Therapy should always be initiated with IV or IM dosing of ketorolac tromethamine, and oral ketorolac tromethamine is to be used only as continuation treatment, if necessary. The total combined duration of use of ketorolac tromethamine injection and oral ketorolac tromethamine is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses (see WARNINGS, PRECAUTIONS, DOSAGE AND ADMINISTRATION, and ADVERSE REACTIONS). Patients should be switched to alternative analgesics as soon as possible, but ketorolac tromethamine therapy is not to exceed 5 days.Ketorolac tromethamine injection has been used concomitantly with morphine and meperidine and has shown an opioid-sparing effect. For breakthrough pain, it is recommended to supplement the lower end of the ketorolac tromethamine injection dosage range with low doses of narcotics prn, unless otherwise contraindicated. Ketorolac tromethamine injection and narcotics should not be administered in the same syringe (see DOSAGE AND ADMINISTRATION – Pharmaceutical Information for Ketorolac Tromethamine Injection). Lidocaine Hydrochloride Injection, USP is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.
11-Digit NDC Billing Format:
76420077101
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Asclemed Usa, Inc.
Dosage Form:
Kit - A packaged collection of related material.
Administration Route(s):
  • Infiltration - Administration that results in substances passing into tissue spaces or into cells.
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Sample Package:
No
Marketing Category:
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date:
08-15-2014
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 76420-771-01?

The NDC Packaged Code 76420-771-01 is assigned to a package of 1 kit in 1 carton * 10 ampule in 1 carton (55150-158-72) / 2 ml in 1 ampule * .9 ml in 1 packet (67777-419-02) * 5 ml in 1 pouch * 1 ml in 1 vial (72266-118-01) of Ketorocaine L Kit, a human prescription drug labeled by Asclemed Usa, Inc.. The product's dosage form is kit and is administered via infiltration; intramuscular; intravenous; topical form.

Is NDC 76420-771 included in the NDC Directory?

Yes, Ketorocaine L Kit with product code 76420-771 is active and included in the NDC Directory. The product was first marketed by Asclemed Usa, Inc. on August 15, 2014 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 76420-771-01?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units.

What is the 11-digit format for NDC 76420-771-01?

The 11-digit format is 76420077101. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-276420-771-015-4-276420-0771-01